Back to Search

GREGORY LYMAN, M.D.

M.D.

Obstetrics & Gynecology Physician

NPI: 1528040375Individual

Specialties, Licenses & Credentials

Obstetrics & Gynecology PhysicianPrimary

Obstetrics & Gynecology

Code: 207V00000X

18131(MS)11401(SC)

Research & Publications (20)

Cost-effectiveness of pegfilgrastim versus 6-day filgrastim primary prophylaxis in patients with non-Hodgkin's lymphoma receiving CHOP-21 in United States.
PMID 19192985·Curr Med Res Opin·2009
8-other
Cost-effectiveness of pegfilgrastim versus filgrastim primary prophylaxis in women with early-stage breast cancer receiving chemotherapy in the United States.
PMID 19539110·Clin Ther·2009
4-observational
Granulocyte colony-stimulating factors: finding the right indication.
PMID 17545791·Curr Opin Oncol·2007
6-review
Summary and comparison of myeloid growth factor guidelines in patients receiving cancer chemotherapy.
PMID 17335690·J Natl Compr Canc Netw·2007
4-observational
Gene expression profile assays as predictors of recurrence-free survival in early-stage breast cancer: a metaanalysis.
PMID 17239261·Clin Breast Cancer·2006
1-meta
Risks and consequences of chemotherapy-induced neutropenia.
PMID 17379159·Clin Cornerstone·2006
6-review
Are there clinical benefits with early erythropoietic intervention for chemotherapy-induced anemia? A systematic review.
PMID 16331597·Cancer·2006
1-meta
Chemotherapy dose intensity and quality cancer care.
PMID 17370925·Oncology (Williston Park)·2006
6-review
The challenge of systematic reviews of diagnostic and staging studies in cancer.
PMID 16225994·Cancer Treat Rev·2005
8-other
Guidelines of the National Comprehensive Cancer Network on the use of myeloid growth factors with cancer chemotherapy: a review of the evidence.
PMID 16038646·J Natl Compr Canc Netw·2005
6-review
American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.
PMID 16157938·J Clin Oncol·2005
6-review
A Southwest Oncology Group Randomized Phase II Study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer.
PMID 15111772·Breast Cancer Res Treat·2004
3-trial
Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma.
PMID 14635075·Cancer·2003
8-other
Risk assessment in oncology clinical practice. From risk factors to risk models.
PMID 14682113·Oncology (Williston Park)·2003
6-review
Filgrastim in patients with neutropenia: potential effects on quality of life.
PMID 12479595·Drugs·2002
6-review
Economic analysis of randomized, controlled trials.
PMID 11489239·Curr Oncol Rep·2001
8-other
Cancer and thrombosis: back to the future renewed interest in an old problem.
PMID 19479483·Cancer Invest·2009
8-other
Comparative effectiveness research in oncology: the need for clarity, transparency and vision.
PMID 19557579·Cancer Invest·2009
8-other
Dose intensity and hematologic toxicity in older breast cancer patients receiving systemic chemotherapy.
PMID 19672945·Cancer·2009
8-other
Treatment of nonmuscle invading bladder cancer: do physicians in the United States practice evidence based medicine? The use and economic implications of intravesical chemotherapy after transurethral resection of bladder tumors.
PMID 19455607·Cancer·2009
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
222 E MEDICAL LN STE 300
WEST COLUMBIA, SC 29169

Location

Practice Location

222 E MEDICAL LN STE 300, WEST COLUMBIA, SC
(803) 936-8100

Quick Facts

NPI
1528040375
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
2
Locations
1
Publications
20

Are you this provider?

Claim Your Profile